CVS Health is exiting its core infusion services business and plans to either close or sell 29 related regional pharmacies in the coming months, a company spokesperson confirmed to Reuters on Friday. Details of the strategic shift were announced in a CVS corporate memo dated Oct. 8 and seen by Reuters. The company on Oct. 8 stopped taking new patients seeking antibiotics, drugs supporting muscular health, and intravenous nutrition services, Shelly Bandit, a senior manager of corporate communications, told Reuters. CVS bought Coram LLC, a drug infusion services provider, for $2.1 billion in 2013.
Read the full article: CVS to Exit Core Infusions Services Business //
Source: https://www.reuters.com/business/healthcare-pharmaceuticals/cvs-exit-core-infusions-services-business-job-cuts-possible-2024-10-11/